|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
The 2006-2011 World Outlook for Antacid Pharmaceutical Preparations Excluding Effervescent Salicylate Analgesics
|
|
1 INTRODUCTION 10
1.1 Overview 10
1.2 What is Latent Demand and the P.I.E.? 10
1.3 The Methodology 11
1.3.1 Step 1. Product Definition and Data Collection 12
1.3.2 Step 2. Filtering and Smoothing 13
1.3.3 Step 3. Filling in Missing Values 13
1.3.4 Step 4. Varying Parameter, Non-linear Estimation 14
1.3.5 Step 5. Fixed-Parameter Linear Estimation 14
1.3.6 Step 6. Aggregation and Benchmarking 15
1.3.7 Step 7. Latent Demand Density: Allocating Across Cities 15
2 SUMMARY OF FINDINGS 16
2.1 The Worldwide Market Potential 16
3 AFRICA, EUROPE & THE MIDDLE EAST 18
3.1 Executive Summary 18
3.2 Afghanistan 19
3.3 Albania 20
3.4 Algeria 21
3.5 Andorra 22
3.6 Angola 22
3.7 Armenia 23
3.8 Austria 24
3.9 Azerbaijan 25
3.10 Bahrain 26
3.11 Belarus 27
3.12 Belgium 28
3.13 Benin 29
3.14 Bosnia and Herzegovina 29
3.15 Botswana 30
3.16 Bulgaria 31
3.17 Burkina Faso 32
3.18 Burundi 33
3.19 Cameroon 33
3.20 Cape Verde 34
3.21 Central African Republic 35
3.22 Chad 35
3.23 Comoros 36
3.24 Congo (formerly Zaire) 37
3.25 Cote d'Ivoire 38
3.26 Croatia 39
3.27 Cyprus 39
3.28 Czech Republic 40
3.29 Denmark 41
3.30 Djibouti 42
3.31 Egypt 42
3.32 Equatorial Guinea 43
3.33 Estonia 44
3.34 Ethiopia 44
3.35 Finland 45
3.36 France 46
3.37 Gabon 47
3.38 Georgia 48
3.39 Germany 49
3.40 Ghana 50
3.41 Greece 51
3.42 Guinea 52
3.43 Guinea-Bissau 52
3.44 Hungary 53
3.45 Iceland 54
3.46 Iran 55
3.47 Iraq 56
3.48 Ireland 57
3.49 Israel 57
3.50 Italy 58
3.51 Jordan 59
3.52 Kazakhstan 60
3.53 Kenya 61
3.54 Kuwait 62
3.55 Kyrgyzstan 63
3.56 Latvia 63
3.57 Lebanon 64
3.58 Lesotho 65
3.59 Liberia 65
3.60 Libya 66
3.61 Liechtenstein 67
3.62 Lithuania 67
3.63 Luxembourg 68
3.64 Madagascar 69
3.65 Malawi 69
3.66 Mali 70
3.67 Malta 71
3.68 Mauritania 71
3.69 Mauritius 72
3.70 Moldova 73
3.71 Monaco 73
3.72 Morocco 74
3.73 Mozambique 75
3.74 Namibia 75
3.75 Netherlands 76
3.76 Niger 77
3.77 Nigeria 77
3.78 Norway 78
3.79 Oman 79
3.80 Pakistan 80
3.81 Palestine 81
3.82 Poland 81
3.83 Portugal 82
3.84 Qatar 83
3.85 Republic of Congo 84
3.86 Reunion 84
3.87 Romania 85
3.88 Russia 86
3.89 Rwanda 87
3.90 San Marino 87
3.91 Sao Tome E Principe 88
3.92 Saudi Arabia 89
3.93 Senegal 90
3.94 Sierra Leone 90
3.95 Slovakia 91
3.96 Slovenia 92
3.97 Somalia 92
3.98 South Africa 93
3.99 Spain 94
3.100 Sudan 95
3.101 Swaziland 96
3.102 Sweden 97
3.103 Switzerland 98
3.104 Syrian Arab Republic 99
3.105 Tajikistan 100
3.106 Tanzania 100
3.107 The Gambia 101
3.108 Togo 102
3.109 Tunisia 103
3.110 Turkey 104
3.111 Turkmenistan 105
3.112 Uganda 105
3.113 Ukraine 106
3.114 United Arab Emirates 107
3.115 United Kingdom 108
3.116 Uzbekistan 109
3.117 Western Sahara 110
3.118 Yemen 110
3.119 Zambia 111
3.120 Zimbabwe 112
4 ASIA 113
4.1 Executive Summary 113
4.2 Bangladesh 114
4.3 Bhutan 115
4.4 Brunei 116
4.5 Burma 116
4.6 Cambodia 117
4.7 China 118
4.8 Hong Kong 119
4.9 India 119
4.10 Indonesia 120
4.11 Japan 121
4.12 Laos 122
4.13 Macau 123
4.14 Malaysia 124
4.15 Maldives 125
4.16 Mongolia 125
4.17 Nepal 126
4.18 North Korea 127
4.19 Papua New Guinea 128
4.20 Philippines 128
4.21 Seychelles 129
4.22 Singapore 130
4.23 South Korea 131
4.24 Sri Lanka 132
4.25 Taiwan 132
4.26 Thailand 133
4.27 Vietnam 134
5 LATIN AMERICA 135
5.1 Executive Summary 135
5.2 Argentina 136
5.3 Belize 137
5.4 Bolivia 138
5.5 Brazil 139
5.6 Chile 140
5.7 Colombia 141
5.8 Costa Rica 142
5.9 Ecuador 142
5.10 El Salvador 143
5.11 Falkland Islands 144
5.12 French Guiana 144
5.13 Guatemala 145
5.14 Guyana 146
5.15 Honduras 146
5.16 Mexico 147
5.17 Nicaragua 148
5.18 Panama 149
5.19 Paraguay 150
5.20 Peru 151
5.21 Suriname 152
5.22 Uruguay 152
5.23 Venezuela 153
6 NORTH AMERICA & THE CARIBBEAN 155
6.1 Executive Summary 155
6.2 Antigua and Barbuda 156
6.3 Aruba 157
6.4 Bahamas 158
6.5 Barbados 158
6.6 Bermuda 159
6.7 British Virgin Islands 160
6.8 Canada 160
6.9 Cayman Islands 161
6.10 Cuba 162
6.11 Dominica 163
6.12 Dominican Republic 163
6.13 Greenland 164
6.14 Grenada 165
6.15 Guadeloupe 166
6.16 Haiti 167
6.17 Jamaica 167
6.18 Martinique 168
6.19 Netherlands Antilles 169
6.20 Puerto Rico 169
6.21 St. Kitts and Nevis 170
6.22 St. Lucia 171
6.23 St. Vincent and the Grenadines 171
6.24 Trinidad and Tobago 172
6.25 United States 173
6.26 Virgin Islands, US 174
7 OCEANA 175
7.1 Executive Summary 175
7.2 American Samoa 176
7.3 Australia 177
7.4 Christmas Island 178
7.5 Cook Islands 178
7.6 Fiji 179
7.7 French Polynesia 180
7.8 Guam 180
7.9 Kiribati 181
7.10 Marshall Islands 182
7.11 Micronesia Federation 182
7.12 Nauru 183
7.13 New Caledonia 184
7.14 New Zealand 184
7.15 Niue 185
7.16 Norfolk Island 186
7.17 Northern Mariana Island 186
7.18 Palau 187
7.19 Solomon Islands 188
7.20 Tokelau 188
7.21 Tonga 189
7.22 Tuvalu 190
7.23 Vanuatu 190
7.24 Wallis and Futuna 191
7.25 Western Samoa 192
8 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 193
8.1 Disclaimers & Safe Harbor 193
8.2 ICON Group International, Inc. User Agreement Provisions 194
|
Similar Products
• Generic Pharmaceuticals Industry Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Top 50 Pharmaceutical Companies Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Top 100 Pharmaceutical Manufacturers Industry Analysis
Published Nov 2009 by Plimsoll Publishing Ltd.
• Pharmaceutical Manufacturers Report - Indian
Published Nov 2009 by Plimsoll Publishing Ltd.
• Pharmaceutical Manufacturers Report - Chinese
Published Nov 2009 by Plimsoll Publishing Ltd.
• Belarus Pharmaceuticals and Healthcare Report Q4 2009
Published Oct 2009 by Business Monitor International
• Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
Published Oct 2009 by Datamonitor
• Pharmaceutical Manufacturers Show Increased Interest in KPO
Published Oct 2009 by IDC
• Lebanon Pharmaceuticals and Healthcare Report Q4 2009
Published Oct 2009 by Business Monitor International
• Antidiabetics in Australia Market Forecast
Published Oct 2009 by Datamonitor
|
|
|
|
0 items
